Skip Navigation


Cardiovascular Research Advance Access first published online on September 25, 2008
This version [Corrected Proof] published online on October 3, 2008
Cardiovascular Research, doi:10.1093/cvr/cvn248
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
81/1/11    most recent
cvn248v3
cvn248v2
cvn248v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dumitriu, I. E.
Right arrow Articles by Kaski, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dumitriu, I. E.
Right arrow Articles by Kaski, J. C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org.

CD4+CD28null T cells in coronary artery disease: when helpers become killers

Ingrid E. Dumitriu, Ernesto Trallero Araguás, Christina Baboonian and Juan Carlos Kaski*

Cardiovascular Biology Research Centre, Division of Cardiac and Vascular Sciences, St George’s University of London, Cranmer Terrace, London SW17 0RE, UK

* Corresponding author. Tel: +44 208 725 5939/5901; fax: +44 208 725 3328. E-mail address: jkaski{at}sgul.ac.uk

The crucial role of T cells in atherosclerosis and coronary artery disease (CAD) has been highlighted by recent observations. Helper CD4+ T cells can both aggravate or attenuate the atherogenic process and the development of CAD. CD4+CD28null T cells are an unusual subset of helper cells which expand and have deleterious effects in CAD. In this review, we discuss the current issues on the generation of CD4+CD28null T cells and focus on their phenotypic and functional characteristics relevant to the development of cardiovascular events. The possible effects of the present day therapies for CAD on the CD4+CD28null T cells are also explored. Targeting the CD4+CD28null T cell subset in CAD could provide novel therapeutic strategies to prevent acute life-threatening coronary events.

KEYWORDS Coronary artery disease; CD4+CD28null T cells

Time for primary review: 15 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.